Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
68.82 USD | -0.66% | -7.43% | +9.92% |
05-22 | Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing | MT |
05-14 | Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.92% | 7.54B | |
+11.97% | 116B | |
+13.10% | 106B | |
-9.91% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.34% | 16.33B | |
+6.42% | 14.14B | |
+30.37% | 12.02B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Insider Sold Shares Worth $706,070, According to a Recent SEC Filing